The CDC findings were released as…
The CDC findings were released as the FDA considers placing [...]
GSK’s depemokimab, a long-acting…
GSK’s depemokimab, a long-acting biologic that’s key to the British [...]
As it shifts strategic direction…
As it shifts strategic direction to prioritize its recently acquired [...]
Thursday, the FDA greenlighted…
Thursday, the FDA greenlighted Uplizna to treat generalized myasthenia gravis [...]
With an increase in the…
With an increase in the antimicrobial resistance to therapies for [...]
Pfizer is paying top dollar for a…
Pfizer is paying top dollar for a GLP-1 candidate from [...]
The long-planned legislation…
The long-planned legislation contains “encouraging steps” but is overall “not [...]
After winning an approval decades…
After winning an approval decades in the making last year—and [...]
About a year and a half after…
About a year and a half after telegraphing plans to [...]
After pressure from the FTC, Teva…
After pressure from the FTC, Teva has asked the FDA [...]